SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-010935
Filing Date
2022-03-07
Accepted
2022-03-07 16:15:11
Documents
12
Period of Report
2022-02-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea156518-8k_enzobio.htm   iXBRL 8-K 22746
  Complete submission text file 0001213900-22-010935.txt   192808

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE enz-20220225.xsd EX-101.SCH 3039
3 XBRL LABEL FILE enz-20220225_lab.xml EX-101.LAB 34476
4 XBRL PRESENTATION FILE enz-20220225_pre.xml EX-101.PRE 22600
6 EXTRACTED XBRL INSTANCE DOCUMENT ea156518-8k_enzobio_htm.xml XML 3469
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 22718161
SIC: 8071 Services-Medical Laboratories